knowledge -WSS

knowledge

author：leisure time 2025-09-27 09:44:27 - browse：79779

Bristol Myers Squibb sign — Courtesy Bristol Myers Squibb

Bristol Myers Squibb said that it would purchase Mirati Therapeutics, maker of the cancer drug Krazati, for $4.8 billion in cash in a deal that shows the continued interest of large pharmaceutical firms in relatively small “bolt-on” acquisitions.

Bristol said that it would pay $58.00 per share for Mirati, and would hold another $12.00 per share, or a total of $1 billion, to be paid if one of two different applications for an additional use for Krazati is approved within seven years after the merger closes.

Chris Boerner, Bristol’s chief operating officer and CEO-elect, said in a statement that Mirati had several cancer drugs in development that could deliver sales in the latter half of the decade and beyond, when investors worry that Bristol will need new products to sustain its growth.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Weekend shootings leave at least 6 dead, 20 others wounded in Chicago

explore

WSS

New requirements coming in 2024 for Americans traveling to Europe

U.K. considers world's first use of meningitis vaccine to address gonorrhea

PBM reforms clear House panel

How to protect coverage of PrEP

Anthos stroke drug appears safer than common blood thinner

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

Wikipedia

knowledge

Wikipedia

Medicare details structure of new drug price negotiation program

Mike Pence ‘not interested in trading insults’ with Trump as he tries to win New Hampshire

Malaria cases in Florida and Texas: Here’s what you need to know

Surge of respiratory disease in China has likely explanation

Walensky prepares to leave CDC — and Congress — behind

4 missing after record

DIEP, the 'gold standard' of breast reconstruction, is under threat

Poor hospice wound care hurts patients and families

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

PrEP can help anyone prevent HIV. Why do so few people take it?

hotspot

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

David Sabatini, ex

Drone hits Crimean ammunition depot as strikes kill, wound civilians and journalists in Ukraine

How to protect coverage of PrEP

Novartis develops a rapidly manufactured CAR

David Sabatini, ex

explore

hotspot

Wikipedia

hotspot